Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT
Clinical trial NCT04862676 · COMPLETED
Trial details
- NCT number
- NCT04862676
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-22
- Primary completion
- 2025-04-04
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.